| Delaware | 001-33216 | 68-0423298 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
| 1129 N. McDowell Blvd. | ||
| Petaluma, California | 94954 | |
| (Address of principal executive offices) | (Zip Code) |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 Results of Operations and Financial Condition | ||||||||
| ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
| 99.1 | Press release issued by Oculus Innovative Sciences, Inc. dated June 11, 2008. |
| OCULUS INNOVATIVE SCIENCES, INC. |
||||
| By: | /s/ Robert Miller | |||
| Robert Miller | ||||
| Chief Financial Officer | ||||
| (title) | ||||